Physician

Ashraf Raslan, M.D.

According to 2025 Medicare claims, Ashraf Raslan, M.D. (NPI: 1023375649) practices rheumatology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is VALLEY PHYSICIAN SERVICES PC (NPI: 1467815928; TIN: 465285330) and primary practice location at 07450-3957. Raslan is affiliated with the ColigoCare, LLC (ACO ID: A3591), participating under the MSSP model.

Raslan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 545 traditional Medicare patients, billed 110,340 HCPCS/CPT codes, and received $1,382,369 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,550 prescription claims across 510 beneficiaries totaling $2,943,410 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 58 records totaling $61,715. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $17,606 to $1,382,369. Similarly, Part D prescription costs have moved sharply higher in recent years, from $65,847 to $2,943,410. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	102	287	$17,606
2017	315	4,805	$205,713
2018	377	5,103	$246,723
2019	389	15,607	$490,811
2020	368	28,345	$817,216
2021	499	78,169	$1,551,919
2022	509	112,847	$1,463,168
2023	549	106,073	$1,317,296
2024	545	110,340	$1,382,369

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	62	142	$65,847
2017	229	847	$126,852
2018	270	1,430	$211,362
2019	320	1,886	$242,121
2020	366	2,315	$509,633
2021	455	2,936	$1,198,119
2022	475	3,133	$1,696,474
2023	505	3,293	$2,235,431
2024	510	3,550	$2,943,410

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	360	649	$105
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	127	168	$76
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	64	342	$58
96372	Injection of drug or substance under skin or into muscle	64	105	$12
36415	Insertion of needle into vein for collection of blood sample	231	345	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	40	1,516	$365,618
Skyrizi Pen	Risankizumab-Rzaa	17	1,316	$333,962
Enbrel Sureclick	Etanercept	35	1,036	$268,080
Otezla	Apremilast	45	1,644	$240,297
Taltz Autoinjector	Ixekizumab	25	784	$218,145

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	57	$907	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$60,808	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ashraf Raslan, M.D.?

Tedicare shows public-source Medicare data for Ashraf Raslan, M.D. (NPI 1023375649), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashraf Raslan, M.D. have ACO affiliation data?

Ashraf Raslan, M.D. is shown with ACO affiliation data for ColigoCare, LLC (MSSP, ACO ID A3591).

What billing organization is linked to Ashraf Raslan, M.D.?

Ashraf Raslan, M.D. is linked to VALLEY PHYSICIAN SERVICES PC (billing NPI 1467815928) in the available physician profile data.

Does Ashraf Raslan, M.D. have Open Payments data?

Ashraf Raslan, M.D. has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.